{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:22:28Z","timestamp":1750220548623,"version":"3.41.0"},"publisher-location":"New York, NY, USA","reference-count":26,"publisher":"ACM","license":[{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,11,6]]},"DOI":"10.1145\/3444884.3444917","type":"proceedings-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T19:08:06Z","timestamp":1617217686000},"page":"171-175","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Overview of Tumor Immunotherapy based on Indoleamine 2,3 Dioxygenase Inhibitors"],"prefix":"10.1145","author":[{"given":"Xiangyu","family":"Hao","sequence":"first","affiliation":[{"name":"China Medical University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"320","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"key":"e_1_3_2_1_1_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.2996"},{"key":"e_1_3_2_1_2_1","doi-asserted-by":"crossref","unstructured":"Wang Y-J Fletcher R Yu J and Zhang L. (2018) Immunogenic effects of chemotherapy-induced tumor cell death. Genes & diseases 5: 194-203.  Wang Y-J Fletcher R Yu J and Zhang L. (2018) Immunogenic effects of chemotherapy-induced tumor cell death. Genes & diseases 5: 194-203.","DOI":"10.1016\/j.gendis.2018.05.003"},{"key":"e_1_3_2_1_3_1","volume-title":"Seminars in cancer biology.","author":"D'Alterio C","year":"2020","unstructured":"D'Alterio C , Scala S , Sozzi G , Roz L and Bertolini G. Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion . in Seminars in cancer biology. 2020 . Elsevier . D'Alterio C, Scala S, Sozzi G, Roz L and Bertolini G. Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion. in Seminars in cancer biology. 2020. Elsevier."},{"key":"e_1_3_2_1_4_1","series-title":"International Journal of Radiation Oncology* Biology* Physics","first-page":"362","volume-title":"Crittenden M R and Gough M J. (2017) Stimulating innate immunity to enhance radiation therapy\u2013induced tumor control","author":"Baird J R","unstructured":"Baird J R , Monjazeb A M , Shah O , McGee H , Murphy W J , Crittenden M R and Gough M J. (2017) Stimulating innate immunity to enhance radiation therapy\u2013induced tumor control . International Journal of Radiation Oncology* Biology* Physics , 99 : 362 - 373 . Baird J R, Monjazeb A M, Shah O, McGee H, Murphy W J, Crittenden M R and Gough M J. (2017) Stimulating innate immunity to enhance radiation therapy\u2013induced tumor control. International Journal of Radiation Oncology* Biology* Physics, 99: 362-373."},{"key":"e_1_3_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2017.06.003"},{"key":"e_1_3_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01572"},{"key":"e_1_3_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110009"},{"key":"e_1_3_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.108"},{"key":"e_1_3_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.12.010"},{"key":"e_1_3_2_1_10_1","volume-title":"Seminars in Cancer Biology.","author":"Guevara M L","year":"2019","unstructured":"Guevara M L , Persano F and Persano S. Nano-immunotherapy: Overcoming tumour immune evasion . in Seminars in Cancer Biology. 2019 . Elsevier . Guevara M L, Persano F and Persano S. Nano-immunotherapy: Overcoming tumour immune evasion. in Seminars in Cancer Biology. 2019. Elsevier."},{"key":"e_1_3_2_1_11_1","volume-title":"Targeting key dioxygenases in tryptophan\u2013kynurenine metabolism for immunomodulation and cancer chemotherapy. Drug discovery today, 20: 609-617","author":"Austin C J","year":"2015","unstructured":"Austin C J and Rendina L M . ( 2015 ) Targeting key dioxygenases in tryptophan\u2013kynurenine metabolism for immunomodulation and cancer chemotherapy. Drug discovery today, 20: 609-617 . Austin C J and Rendina L M. (2015) Targeting key dioxygenases in tryptophan\u2013kynurenine metabolism for immunomodulation and cancer chemotherapy. Drug discovery today, 20: 609-617."},{"key":"e_1_3_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.07.012"},{"key":"e_1_3_2_1_13_1","volume-title":"Indoleamine 2, 3-dioxygenase in immune suppression and cancer. Current cancer drug targets, 7: 31-40","author":"Muller A J","year":"2007","unstructured":"Muller A J and Prendergast G C . ( 2007 ) Indoleamine 2, 3-dioxygenase in immune suppression and cancer. Current cancer drug targets, 7: 31-40 . Muller A J and Prendergast G C. (2007) Indoleamine 2, 3-dioxygenase in immune suppression and cancer. Current cancer drug targets, 7: 31-40."},{"key":"e_1_3_2_1_14_1","doi-asserted-by":"crossref","unstructured":"Adams J L Smothers J Srinivasan R and Hoos A. (2015) Big opportunities for small molecules in immuno-oncology. Nature reviews Drug discovery 14: 603-622.  Adams J L Smothers J Srinivasan R and Hoos A. (2015) Big opportunities for small molecules in immuno-oncology. Nature reviews Drug discovery 14: 603-622.","DOI":"10.1038\/nrd4596"},{"key":"e_1_3_2_1_15_1","volume-title":"Molecules in focus: indoleamine 2, 3-dioxygenase. The international journal of biochemistry & cell biology, 39: 2167-2172","author":"King N J","year":"2007","unstructured":"King N J and Thomas S R . ( 2007 ) Molecules in focus: indoleamine 2, 3-dioxygenase. The international journal of biochemistry & cell biology, 39: 2167-2172 . King N J and Thomas S R. (2007) Molecules in focus: indoleamine 2, 3-dioxygenase. The international journal of biochemistry & cell biology, 39: 2167-2172."},{"volume-title":"In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; ; . 2013 Apr 6-10","author":"Mario R.","key":"e_1_3_2_1_16_1","unstructured":"Mario R. Mautino F A J , Jesse Waldo , Sanjeev Kumar, James Adams , Clarissa Van Allen, Agnieszka Marcinowicz-Flick , David Munn, Nicholas Vahanian , Charles J. Link . NLG919 , a novel indoleamine-2,3-dioxygenase (IDO)-pathway inhibitor drug candidate for cancer therapy . . in In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; ; . 2013 Apr 6-10 . Washington, DC. Philadelphia (PA):. Mario R. Mautino F A J, Jesse Waldo, Sanjeev Kumar, James Adams, Clarissa Van Allen, Agnieszka Marcinowicz-Flick, David Munn, Nicholas Vahanian, Charles J. Link. NLG919, a novel indoleamine-2,3-dioxygenase (IDO)-pathway inhibitor drug candidate for cancer therapy. . in In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; ; . 2013 Apr 6-10. Washington, DC. Philadelphia (PA):."},{"key":"e_1_3_2_1_17_1","doi-asserted-by":"crossref","unstructured":"Li\n      F Zhang\n      R Li S and Liu J. (2017) IDO1: an important immunotherapy target in cancer treatment\n  . \n  International immunopharmacology 47\n  : \n  70\n  -\n  77\n  .  Li F Zhang R Li S and Liu J. (2017) IDO1: an important immunotherapy target in cancer treatment. International immunopharmacology 47: 70-77.","DOI":"10.1016\/j.intimp.2017.03.024"},{"key":"e_1_3_2_1_18_1","first-page":"3520","article-title":"Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity","volume":"115","author":"Liu X","year":"2010","unstructured":"Liu X , Shin N , Koblish H K , Yang G , Wang Q , Wang K , Leffet L , Hansbury M J , Thomas B and Rupar M. ( 2010 ) Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity . Blood, The Journal of the American Society of Hematology , 115 : 3520 - 3530 . Liu X, Shin N, Koblish H K, Yang G, Wang Q, Wang K, Leffet L, Hansbury M J, Thomas B and Rupar M. (2010) Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity. Blood, The Journal of the American Society of Hematology, 115: 3520-3530.","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"e_1_3_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.27.15_suppl.3004"},{"key":"e_1_3_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2357"},{"key":"e_1_3_2_1_21_1","doi-asserted-by":"crossref","unstructured":"Rosenblum D Joshi N Tao W Karp J M and Peer D. (2018) Progress and challenges towards targeted delivery of cancer therapeutics. Nature communications 9: 1-12.  Rosenblum D Joshi N Tao W Karp J M and Peer D. (2018) Progress and challenges towards targeted delivery of cancer therapeutics. Nature communications 9: 1-12.","DOI":"10.1038\/s41467-018-03705-y"},{"key":"e_1_3_2_1_22_1","volume-title":"Delivering nanomedicine to solid tumors. Nature reviews Clinical oncology, 7: 653","author":"Jain R K","year":"2010","unstructured":"Jain R K and Stylianopoulos T . ( 2010 ) Delivering nanomedicine to solid tumors. Nature reviews Clinical oncology, 7: 653 . Jain R K and Stylianopoulos T. (2010) Delivering nanomedicine to solid tumors. Nature reviews Clinical oncology, 7: 653."},{"key":"e_1_3_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.83"},{"key":"e_1_3_2_1_24_1","doi-asserted-by":"crossref","unstructured":"Ye Y Wang J Hu Q Hochu G M Xin H Wang C and Gu Z. (2016) Synergistic transcutaneous immunotherapy enhances antitumor immune responses through delivery of checkpoint inhibitors. ACS nano 10: 8956-8963.  Ye Y Wang J Hu Q Hochu G M Xin H Wang C and Gu Z. (2016) Synergistic transcutaneous immunotherapy enhances antitumor immune responses through delivery of checkpoint inhibitors. ACS nano 10: 8956-8963.","DOI":"10.1021\/acsnano.6b04989"},{"key":"e_1_3_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2017.44"},{"key":"e_1_3_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201803001"}],"event":{"name":"ICBBE '20: 2020 7th International Conference on Biomedical and Bioinformatics Engineering","acronym":"ICBBE '20","location":"Kyoto Japan"},"container-title":["2020 7th International Conference on Biomedical and Bioinformatics Engineering"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3444884.3444917","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3444884.3444917","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T21:28:13Z","timestamp":1750195693000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3444884.3444917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,6]]},"references-count":26,"alternative-id":["10.1145\/3444884.3444917","10.1145\/3444884"],"URL":"https:\/\/doi.org\/10.1145\/3444884.3444917","relation":{},"subject":[],"published":{"date-parts":[[2020,11,6]]},"assertion":[{"value":"2021-03-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}